nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Mouth ulceration—Doxorubicin—sarcoma	0.00258	0.00258	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Cefuroxime—Convulsion—Vincristine—sarcoma	0.00257	0.00257	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Epirubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Cefuroxime—Cough—Mitoxantrone—sarcoma	0.00252	0.00252	CcSEcCtD
Cefuroxime—Angiopathy—Etoposide—sarcoma	0.00251	0.00251	CcSEcCtD
Cefuroxime—Convulsion—Mitoxantrone—sarcoma	0.0025	0.0025	CcSEcCtD
Cefuroxime—Immune system disorder—Etoposide—sarcoma	0.00249	0.00249	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00249	0.00249	CcSEcCtD
Cefuroxime—Chills—Etoposide—sarcoma	0.00248	0.00248	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00247	0.00247	CcSEcCtD
Cefuroxime—Arthralgia—Mitoxantrone—sarcoma	0.00246	0.00246	CcSEcCtD
Cefuroxime—Chest pain—Mitoxantrone—sarcoma	0.00246	0.00246	CcSEcCtD
Cefuroxime—Somnolence—Thiotepa—sarcoma	0.00243	0.00243	CcSEcCtD
Cefuroxime—Anaphylactic shock—Vincristine—sarcoma	0.00242	0.00242	CcSEcCtD
Cefuroxime—Dyspepsia—Thiotepa—sarcoma	0.0024	0.0024	CcSEcCtD
Cefuroxime—Thrombophlebitis—Doxorubicin—sarcoma	0.00239	0.00239	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Cefuroxime—Decreased appetite—Thiotepa—sarcoma	0.00237	0.00237	CcSEcCtD
Cefuroxime—Thrombocytopenia—Vincristine—sarcoma	0.00237	0.00237	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Doxorubicin—sarcoma	0.00237	0.00237	CcSEcCtD
Cefuroxime—Anaphylactic shock—Mitoxantrone—sarcoma	0.00236	0.00236	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Thiotepa—sarcoma	0.00236	0.00236	CcSEcCtD
Cefuroxime—Decreased appetite—Dactinomycin—sarcoma	0.00236	0.00236	CcSEcCtD
Cefuroxime—Renal impairment—Epirubicin—sarcoma	0.00235	0.00235	CcSEcCtD
Cefuroxime—Hyperhidrosis—Vincristine—sarcoma	0.00234	0.00234	CcSEcCtD
Cefuroxime—Pain—Thiotepa—sarcoma	0.00234	0.00234	CcSEcCtD
Cefuroxime—Pain—Dactinomycin—sarcoma	0.00232	0.00232	CcSEcCtD
Cefuroxime—Muscle spasms—Etoposide—sarcoma	0.00231	0.00231	CcSEcCtD
Cefuroxime—Thrombocytopenia—Mitoxantrone—sarcoma	0.00231	0.00231	CcSEcCtD
Cefuroxime—Anorexia—Vincristine—sarcoma	0.00231	0.00231	CcSEcCtD
Cefuroxime—Tachycardia—Mitoxantrone—sarcoma	0.0023	0.0023	CcSEcCtD
Cefuroxime—Skin disorder—Mitoxantrone—sarcoma	0.00229	0.00229	CcSEcCtD
Cefuroxime—Hyperhidrosis—Mitoxantrone—sarcoma	0.00228	0.00228	CcSEcCtD
Cefuroxime—Anorexia—Mitoxantrone—sarcoma	0.00225	0.00225	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Thiotepa—sarcoma	0.00223	0.00223	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dactinomycin—sarcoma	0.00222	0.00222	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Vincristine—sarcoma	0.00221	0.00221	CcSEcCtD
Cefuroxime—Renal impairment—Doxorubicin—sarcoma	0.00218	0.00218	CcSEcCtD
Cefuroxime—Urticaria—Thiotepa—sarcoma	0.00217	0.00217	CcSEcCtD
Cefuroxime—Abdominal pain—Thiotepa—sarcoma	0.00216	0.00216	CcSEcCtD
Cefuroxime—Body temperature increased—Thiotepa—sarcoma	0.00216	0.00216	CcSEcCtD
Cefuroxime—Leukopenia—Etoposide—sarcoma	0.00215	0.00215	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00215	0.00215	CcSEcCtD
Cefuroxime—Body temperature increased—Dactinomycin—sarcoma	0.00214	0.00214	CcSEcCtD
Cefuroxime—Abdominal pain—Dactinomycin—sarcoma	0.00214	0.00214	CcSEcCtD
Cefuroxime—Decreased appetite—Vincristine—sarcoma	0.00211	0.00211	CcSEcCtD
Cefuroxime—Dyspnoea—Mitoxantrone—sarcoma	0.0021	0.0021	CcSEcCtD
Cefuroxime—Cough—Etoposide—sarcoma	0.0021	0.0021	CcSEcCtD
Cefuroxime—Somnolence—Mitoxantrone—sarcoma	0.0021	0.0021	CcSEcCtD
Cefuroxime—Blood creatinine increased—Epirubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Vincristine—sarcoma	0.00209	0.00209	CcSEcCtD
Cefuroxime—Convulsion—Etoposide—sarcoma	0.00208	0.00208	CcSEcCtD
Cefuroxime—Dyspepsia—Mitoxantrone—sarcoma	0.00208	0.00208	CcSEcCtD
Cefuroxime—Pain—Vincristine—sarcoma	0.00207	0.00207	CcSEcCtD
Cefuroxime—Decreased appetite—Mitoxantrone—sarcoma	0.00205	0.00205	CcSEcCtD
Cefuroxime—Chest pain—Etoposide—sarcoma	0.00205	0.00205	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00203	0.00203	CcSEcCtD
Cefuroxime—Pain—Mitoxantrone—sarcoma	0.00202	0.00202	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Cefuroxime—Hypersensitivity—Thiotepa—sarcoma	0.00201	0.00201	CcSEcCtD
Cefuroxime—Hypersensitivity—Dactinomycin—sarcoma	0.002	0.002	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Vincristine—sarcoma	0.00198	0.00198	CcSEcCtD
Cefuroxime—Anaphylactic shock—Etoposide—sarcoma	0.00196	0.00196	CcSEcCtD
Cefuroxime—Blood creatinine increased—Doxorubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Cefuroxime—Pruritus—Thiotepa—sarcoma	0.00193	0.00193	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00193	0.00193	CcSEcCtD
Cefuroxime—Thrombocytopenia—Etoposide—sarcoma	0.00192	0.00192	CcSEcCtD
Cefuroxime—Tachycardia—Etoposide—sarcoma	0.00191	0.00191	CcSEcCtD
Cefuroxime—Eosinophilia—Epirubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Cefuroxime—Abdominal pain—Vincristine—sarcoma	0.00191	0.00191	CcSEcCtD
Cefuroxime—Body temperature increased—Vincristine—sarcoma	0.00191	0.00191	CcSEcCtD
Cefuroxime—Skin disorder—Etoposide—sarcoma	0.00191	0.00191	CcSEcCtD
Cefuroxime—Hyperhidrosis—Etoposide—sarcoma	0.0019	0.0019	CcSEcCtD
Cefuroxime—Urticaria—Mitoxantrone—sarcoma	0.00187	0.00187	CcSEcCtD
Cefuroxime—Anorexia—Etoposide—sarcoma	0.00187	0.00187	CcSEcCtD
Cefuroxime—Diarrhoea—Thiotepa—sarcoma	0.00187	0.00187	CcSEcCtD
Cefuroxime—Abdominal pain—Mitoxantrone—sarcoma	0.00186	0.00186	CcSEcCtD
Cefuroxime—Body temperature increased—Mitoxantrone—sarcoma	0.00186	0.00186	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Cefuroxime—Bronchitis—Epirubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Cefuroxime—Diarrhoea—Dactinomycin—sarcoma	0.00185	0.00185	CcSEcCtD
Cefuroxime—Pancytopenia—Epirubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Cefuroxime—Dysuria—Epirubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Cefuroxime—Neutropenia—Epirubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Cefuroxime—Dizziness—Thiotepa—sarcoma	0.00181	0.00181	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Epirubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Cefuroxime—Hypersensitivity—Vincristine—sarcoma	0.00178	0.00178	CcSEcCtD
Cefuroxime—Eosinophilia—Doxorubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Cefuroxime—Dyspnoea—Etoposide—sarcoma	0.00175	0.00175	CcSEcCtD
Cefuroxime—Somnolence—Etoposide—sarcoma	0.00174	0.00174	CcSEcCtD
Cefuroxime—Hypersensitivity—Mitoxantrone—sarcoma	0.00174	0.00174	CcSEcCtD
Cefuroxime—Vomiting—Thiotepa—sarcoma	0.00174	0.00174	CcSEcCtD
Cefuroxime—Drowsiness—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Cefuroxime—Infestation NOS—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Cefuroxime—Infestation—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Cefuroxime—Vomiting—Dactinomycin—sarcoma	0.00172	0.00172	CcSEcCtD
Cefuroxime—Rash—Thiotepa—sarcoma	0.00172	0.00172	CcSEcCtD
Cefuroxime—Bronchitis—Doxorubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Cefuroxime—Dermatitis—Thiotepa—sarcoma	0.00172	0.00172	CcSEcCtD
Cefuroxime—Headache—Thiotepa—sarcoma	0.00171	0.00171	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Cefuroxime—Rash—Dactinomycin—sarcoma	0.00171	0.00171	CcSEcCtD
Cefuroxime—Decreased appetite—Etoposide—sarcoma	0.00171	0.00171	CcSEcCtD
Cefuroxime—Pancytopenia—Doxorubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Cefuroxime—Renal failure—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Etoposide—sarcoma	0.00169	0.00169	CcSEcCtD
Cefuroxime—Stomatitis—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Cefuroxime—Jaundice—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Cefuroxime—Pain—Etoposide—sarcoma	0.00168	0.00168	CcSEcCtD
Cefuroxime—Urinary tract infection—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Cefuroxime—Diarrhoea—Vincristine—sarcoma	0.00166	0.00166	CcSEcCtD
Cefuroxime—Sweating—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Cefuroxime—Nausea—Thiotepa—sarcoma	0.00162	0.00162	CcSEcCtD
Cefuroxime—Sinusitis—Epirubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Cefuroxime—Diarrhoea—Mitoxantrone—sarcoma	0.00161	0.00161	CcSEcCtD
Cefuroxime—Nausea—Dactinomycin—sarcoma	0.00161	0.00161	CcSEcCtD
Cefuroxime—Agranulocytosis—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Etoposide—sarcoma	0.0016	0.0016	CcSEcCtD
Cefuroxime—Dizziness—Vincristine—sarcoma	0.0016	0.0016	CcSEcCtD
Cefuroxime—Infestation NOS—Doxorubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefuroxime—Renal failure—Doxorubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Cefuroxime—Urticaria—Etoposide—sarcoma	0.00156	0.00156	CcSEcCtD
Cefuroxime—Haemoglobin—Epirubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Cefuroxime—Abdominal pain—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Cefuroxime—Body temperature increased—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Cefuroxime—Hepatitis—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Cefuroxime—Haemorrhage—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Cefuroxime—Vomiting—Vincristine—sarcoma	0.00154	0.00154	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Cefuroxime—Urinary tract disorder—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Cefuroxime—Rash—Vincristine—sarcoma	0.00153	0.00153	CcSEcCtD
Cefuroxime—Dermatitis—Vincristine—sarcoma	0.00153	0.00153	CcSEcCtD
Cefuroxime—Urethral disorder—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Cefuroxime—Headache—Vincristine—sarcoma	0.00152	0.00152	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Cefuroxime—Vomiting—Mitoxantrone—sarcoma	0.0015	0.0015	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Cefuroxime—Rash—Mitoxantrone—sarcoma	0.00149	0.00149	CcSEcCtD
Cefuroxime—Dermatitis—Mitoxantrone—sarcoma	0.00149	0.00149	CcSEcCtD
Cefuroxime—Headache—Mitoxantrone—sarcoma	0.00148	0.00148	CcSEcCtD
Cefuroxime—Erythema multiforme—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Cefuroxime—Hypersensitivity—Etoposide—sarcoma	0.00145	0.00145	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Cefuroxime—Nausea—Vincristine—sarcoma	0.00144	0.00144	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Cefuroxime—Angiopathy—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Cefuroxime—Nausea—Mitoxantrone—sarcoma	0.0014	0.0014	CcSEcCtD
Cefuroxime—Immune system disorder—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Cefuroxime—Chills—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Cefuroxime—Pruritus—Etoposide—sarcoma	0.00139	0.00139	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Cefuroxime—Erythema—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Cefuroxime—Diarrhoea—Etoposide—sarcoma	0.00134	0.00134	CcSEcCtD
Cefuroxime—Flatulence—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Cefuroxime—Dizziness—Etoposide—sarcoma	0.0013	0.0013	CcSEcCtD
Cefuroxime—Muscle spasms—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Cefuroxime—Vomiting—Etoposide—sarcoma	0.00125	0.00125	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Cefuroxime—Agitation—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Cefuroxime—Rash—Etoposide—sarcoma	0.00124	0.00124	CcSEcCtD
Cefuroxime—Dermatitis—Etoposide—sarcoma	0.00124	0.00124	CcSEcCtD
Cefuroxime—Headache—Etoposide—sarcoma	0.00123	0.00123	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Cefuroxime—Leukopenia—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Cefuroxime—Palpitations—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Cefuroxime—Cough—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Cefuroxime—Convulsion—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Cefuroxime—Nausea—Etoposide—sarcoma	0.00117	0.00117	CcSEcCtD
Cefuroxime—Chest pain—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Cefuroxime—Arthralgia—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Cefuroxime—Anaphylactic shock—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Cefuroxime—Thrombocytopenia—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Cefuroxime—Tachycardia—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Cefuroxime—Skin disorder—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Cefuroxime—Hyperhidrosis—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Cefuroxime—Anorexia—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Epirubicin—sarcoma	0.001	0.001	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—sarcoma	0.000996	0.000996	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—sarcoma	0.000993	0.000993	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—sarcoma	0.000988	0.000988	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—sarcoma	0.000984	0.000984	CcSEcCtD
Cefuroxime—Dyspnoea—Epirubicin—sarcoma	0.00098	0.00098	CcSEcCtD
Cefuroxime—Somnolence—Epirubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—sarcoma	0.00097	0.00097	CcSEcCtD
Cefuroxime—Dyspepsia—Epirubicin—sarcoma	0.000968	0.000968	CcSEcCtD
Cefuroxime—Decreased appetite—Epirubicin—sarcoma	0.000956	0.000956	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Epirubicin—sarcoma	0.000949	0.000949	CcSEcCtD
Cefuroxime—Pain—Epirubicin—sarcoma	0.00094	0.00094	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000927	0.000927	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—sarcoma	0.000907	0.000907	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—sarcoma	0.000905	0.000905	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Epirubicin—sarcoma	0.000899	0.000899	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—sarcoma	0.000896	0.000896	CcSEcCtD
Cefuroxime—Decreased appetite—Doxorubicin—sarcoma	0.000885	0.000885	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000879	0.000879	CcSEcCtD
Cefuroxime—Urticaria—Epirubicin—sarcoma	0.000874	0.000874	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—sarcoma	0.00087	0.00087	CcSEcCtD
Cefuroxime—Abdominal pain—Epirubicin—sarcoma	0.000869	0.000869	CcSEcCtD
Cefuroxime—Body temperature increased—Epirubicin—sarcoma	0.000869	0.000869	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—sarcoma	0.000832	0.000832	CcSEcCtD
Cefuroxime—Hypersensitivity—Epirubicin—sarcoma	0.00081	0.00081	CcSEcCtD
Cefuroxime—Urticaria—Doxorubicin—sarcoma	0.000808	0.000808	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—sarcoma	0.000804	0.000804	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—sarcoma	0.000804	0.000804	CcSEcCtD
Cefuroxime—Pruritus—Epirubicin—sarcoma	0.000778	0.000778	CcSEcCtD
Cefuroxime—Diarrhoea—Epirubicin—sarcoma	0.000752	0.000752	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—sarcoma	0.00075	0.00075	CcSEcCtD
Cefuroxime—Dizziness—Epirubicin—sarcoma	0.000727	0.000727	CcSEcCtD
Cefuroxime—Pruritus—Doxorubicin—sarcoma	0.00072	0.00072	CcSEcCtD
Cefuroxime—Vomiting—Epirubicin—sarcoma	0.000699	0.000699	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—sarcoma	0.000696	0.000696	CcSEcCtD
Cefuroxime—Rash—Epirubicin—sarcoma	0.000693	0.000693	CcSEcCtD
Cefuroxime—Dermatitis—Epirubicin—sarcoma	0.000693	0.000693	CcSEcCtD
Cefuroxime—Headache—Epirubicin—sarcoma	0.000689	0.000689	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—sarcoma	0.000673	0.000673	CcSEcCtD
Cefuroxime—Nausea—Epirubicin—sarcoma	0.000653	0.000653	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—sarcoma	0.000647	0.000647	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—sarcoma	0.000642	0.000642	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—sarcoma	0.000641	0.000641	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—sarcoma	0.000637	0.000637	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—sarcoma	0.000604	0.000604	CcSEcCtD
